Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,545,000 | 6,467,000 | 5,346,000 | 6,221,000 | 5,623,000 |
| Marketable Securities | 397,000 | 562,000 | 573,000 | 622,000 | 391,000 |
| Inventories | 4,064,000 | 4,193,000 | 3,910,000 | 4,107,000 | 4,056,000 |
| Other current assets | 6,564,000 | 6,119,000 | 5,420,000 | 6,017,000 | 7,199,000 |
| TOTAL | $17,570,000 | $17,341,000 | $15,249,000 | $16,967,000 | $17,269,000 |
| Non-Current Assets | |||||
| PPE Net | 9,374,000 | 9,380,000 | 8,875,000 | 9,441,000 | 9,678,000 |
| Intangibles | 11,544,000 | 10,555,000 | 7,802,000 | 8,304,000 | 7,970,000 |
| Other Non-Current Assets | 4,374,000 | 4,171,000 | 4,035,000 | 4,455,000 | 4,476,000 |
| TOTAL | $25,292,000 | $24,106,000 | $20,712,000 | $22,200,000 | $22,124,000 |
| Total Assets | $42,862,000 | $41,447,000 | $35,961,000 | $39,167,000 | $39,393,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,471,000 | 1,886,000 | 1,185,000 | 1,276,000 | 956,000 |
| Accounts payable and accrued liabilities | 6,772,000 | 6,084,000 | 5,161,000 | 5,752,000 | 6,075,000 |
| Other current liabilities | 168,000 | 241,000 | 400,000 | 254,000 | 752,000 |
| TOTAL | $12,118,000 | $11,120,000 | $9,034,000 | $9,746,000 | $10,017,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,786,000 | 15,035,000 | 13,067,000 | 15,106,000 | 15,231,000 |
| Other Non-Current Liabilities | 3,834,000 | 4,613,000 | 5,018,000 | 4,792,000 | 4,726,000 |
| TOTAL | $20,002,000 | $20,693,000 | $18,896,000 | $20,987,000 | $21,058,000 |
| Total Liabilities | $32,120,000 | $31,813,000 | $27,930,000 | $30,733,000 | $31,075,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,416,000 | 1,416,000 | 1,416,000 | 1,416,000 | 1,415,000 |
| Retained earnings | 6,321,000 | 5,701,000 | 4,257,000 | 4,619,000 | 4,622,000 |
| Other shareholders' equity | 900,000 | 819,000 | 703,000 | 687,000 | 568,000 |
| TOTAL | $10,005,000 | $9,280,000 | $7,717,000 | $8,062,000 | $7,931,000 |
| Total Liabilities And Equity | $42,125,000 | $41,093,000 | $35,647,000 | $38,795,000 | $39,006,000 |